ATM and B-cell chronic lymphocytic leukemia: In addition, WES studies from more than 1000 CLL samples were not able to identify any statistical evidence for a specific pattern of co‐occurrence or mutual exclusivity of ATM and TP53 genetic alterations in CLL.4, 5